Explore the words cloud of the AQUAGARLIC project. It provides you a very rough idea of what is the project "AQUAGARLIC" about.
The following table provides information about the project.
Coordinator |
DOMCA SA
Organization address contact info |
Coordinator Country | Spain [ES] |
Total cost | 71˙429 € |
EC max contribution | 50˙000 € (70%) |
Programme |
1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies) |
Code Call | H2020-SMEInst-2018-2020-1 |
Funding Scheme | SME-1 |
Starting year | 2019 |
Duration (year-month-day) | from 2019-11-01 to 2020-02-29 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | DOMCA SA | ES (ALHENDIN GRANADA) | coordinator | 50˙000.00 |
Domca is a Spanish company with more than 40 years of experience offering turnkey solutions for the agri-food and animal feeding sector. One of our key points is the development and production of products for animal nutrition, extracted from natural products and manufactured under strict standards. A sample of our experience, is the line of animal nutrition products, which based on extracts of Aliaceae, nourish and improve the performance and growth of terrestrial animals. Diseases on aquacultured fish are a clear indicator of the presence of pathogens (normally microbes &/or parasites). These pathogens can cause health problems to humans when eating the infected fish. Beside this, loss of yield in aquaculture production can rise up to 50% due to this situation. The objective of this Phase I project, AQUAgarlic, is to create a feasibility study for the launching of Domca’s new product in the aquaculture market, with the first dual action (antimicrobial and immunomodulator) feed additive for aquaculture industry based on organosulfur natural active ingredients, with zero residues, effective and environmentally friendly, expanding our sales portfolio while we enter a market of € 1.05 billion (CAGR of 3.2%). This product would be a game changer, as most related products (synthetic medicines) are not environmentally friendly and are targeted to only one specific threat (microbe or parasite). To ensure a smooth take-off in the market, we have a team specialized in controlling the distribution operations in Europe, Africa and Asia, as well as subsidiary companies in Chile and Argentina, which will be in charge of market introduction in Latam. Upon completion of this project, Domca will submit a Horizon 2020 SME-Phase II proposal to the industrialization and market launching.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "AQUAGARLIC" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "AQUAGARLIC" are provided by the European Opendata Portal: CORDIS opendata.
INSIGHTS FOR TALENT ASSESSMENT USING COMPUTER VISION TECHNIQUES FROM NEURO PSYCHOLOGY
Read MoreTracworx is a data analytics tool that allows you to establish bottlenecks in your patient flow, while understanding your efficiencies and ultimately your true capacity.
Read More